Friday 6 November 2026
Export GRDN’s income statement to Excel — free account
Guardian Pharmacy Services, Inc.
GRDN Healthcare Medical Care Facilities
Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.
- Revenue
- −1.68%
- EPS
- +133.3%
- Free cash flow
- +88.9%
Quarter to September 2026, against a year earlier
39.72
2.37
−5.63%
Follow GRDN
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| 31.47% | 30.14% | 26.83% | 26.76% |
+8 more TTM periods Free account |
|
| 16.96% | 16.48% | 13.95% | 13.42% | ||
ROIC |
36.76% | 31.82% | 28.86% | 29.83% | |
Return on Tangible Assets |
43.18% | 41.94% | 40.43% | 42.27% | |
Average Days of Receivables |
26.97 | 25.88 | 28.00 | 25.60 | |
Free Cash Flow per Share |
0.00 | 1.26 | 1.11 | 1.29 | |
Free Cash Flow |
114.06 | 79.79 | 70.28 | 80.71 | |
Capital Expenditures |
— | (19.07) | (18.49) | (19.54) | |
| Other line items | |||||
Cash ROIC |
28.56% | 22.96% | 23.64% | 28.46% | |
Accounts Receivable Turnover |
13.63 | 14.79 | 13.93 | 14.58 | |
Accounts Payable Turnover |
9.11 | 10.76 | 10.95 | 10.57 | |
Inventory Turnover |
21.54 | 24.25 | 25.42 | 27.55 | |
Average Days of Payables |
40.80 | 34.44 | 34.41 | 36.69 | |
Days of Inventory on Hand |
18.43 | 16.05 | 14.95 | 13.69 | |
Tax Rate |
(0.28) | (0.31) | (0.32) | (0.33) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
15.99% | 15.79% | 15.61% | 15.19% | |
Share Based Compensation of Revenue |
0.59% | 0.70% | 0.81% | 0.96% | |
Interest Coverage |
145.28 | 135.40 | 119.22 | 109.32 | |
Operating CF/Net income |
1.53 | 1.50 | 1.67 | 2.04 | |
Depreciation/Fixed assets |
0.41 | 0.41 | 0.41 | 0.40 | |
Capex/Depreciation |
0.00 | (0.82) | (0.80) | (0.88) | |
Revenue per Share |
0.00 | 23.11 | 22.99 | 23.22 | |
Operating CF per Share |
0.00 | 1.56 | 1.40 | 1.61 | |
Capex per Share |
— | (0.30) | (0.29) | (0.31) | |
Capex to Sales |
0.00 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 5 Nov 2026